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INTRODUCTION
Arachidonylethanolamide is an endogenously produced fatty acid ethanolamide that activates cannabinoid receptors to produce cellular and pharmacological effects similar to ∆ 9 -THC, the psychoactive component of marijuana (for reviews Howlett et al. 2002; Pacher et al., 2006) . However, several reports indicate that AEA can produce effects that are not mediated by the activation of the cloned CB 1 or CB 2 receptors. For example, it has been demonstrated that AEA inhibits the functions of voltage-dependent-Ca 2+ channels (Oz et al., 2000; Chemin et al., 2001) , Na + channels (Nicholson et al., 2003) , various types of K + channels (Poling et al., 1996; Oliver, 2004) , 5-HT 3 receptor function (Barann et al., 2002; Oz et al., 2002a) , and nicotinic ACh receptors (Oz et al., 2003) in a cannabinoid receptor-independent manner (for a review Oz ., 2006) . These findings can suggest that additional molecular targets for AEA exist in the CNS.
The nAChR containing α 4β2 subunits, the predominant subtype in the CNS, has been linked to the positive-reinforcing and cognitive effects of nicotine (Tapper et al., 2004; Brody et al., 2006) , and its high affinity for nicotine has lead to the proposal that it is a primary target for nicotine's actions in the CNS (Laviolette and van der Kooy, 2004) .
In support of this view, recent studies with mutant mice demonstrated that the α 4β2
nAChR was necessary to observe tolerance and sensitization to nicotine in vivo (Tapper et al., 2004) . Biochemical, electrophysiological, behavioral, and clinical evidence support the existence of functional interactions between nicotinic receptors and cannabinoids, including AEA (for reviews Castane et al., 2006; Viveros et al., 2006) . In addition, we have shown that the endogenous cannabinoid AEA inhibits ion currents This article has not been copyedited and formatted. The final version may differ from this version. (Oz et al., 2003) .
To date, the functional interaction between α 4β2 nAChR and cannabinoid receptor ligands such as AEA and ∆ 9 -THC has not been investigated. In the present study, we examine the effects of these cannabinoids on the function of α 4β2 nAChR receptors stably transfected in the SH-EP1 cell line.
This article has not been copyedited and formatted. The final version may differ from this version. 
MATERIALS AND METHODS
Cell Culture
The SH-EP1 cells stably expressing the human α 4β2 nAChR, a gift from Dr. R Lukas (Barrow Neurological Institute, Phoenix, AZ), are described elsewhere (Pacheco et al., 2001) . They were grown on 35 mm dishes in DMEM (Gibco, Gaithersberg, MD) supplemented with 10% heat inactivated horse serum (Gibco), 5% fetal bovine serum (Gibco), 1 mM sodium pyruvate, 100 U/mL penicillin G, 100 µ g/mL streptomycin, 0.25 µ g/mL amphotericin B, 0.4 mg/mL hygromycin B, and 0.25 mg/mL Zeocin (Gibco). The cells were maintained at 37 o C in an atmosphere of 5% CO 2 saturated with H 2 O.
Electrophysiological Recording
The cells were recorded at ambient temperature while superfused at 2.0 mL/min Acetylcholine was used as the agonist to probe receptor function. We preferred it over other agonists mostly because of its low hydrophobicity, making it easy to wash out, and because, unlike nicotine, it has limited ability to desensitize the α 4β2 nAChRs (Paradiso and Steinbach, 2003 where x and y are concentration and response, respectively, E max is the maximal response, EC 50 is the half-maximal concentration, and n is the slope factor (apparent Hill coefficient). For data analysis and calculations of concentration response curve data, we used the computer program MLAB (Civilized Software, Bethesda, MD).
The kinetic analyses of the current decays were performed using the modeling program MLAB. A more intuitive explanation is given in the supplementary materials.
The kinetic analysis incorporated only the decay phases of the responses because the kinetics of the rising phases were limited by various parameters including the cell size, the unstirred layer (Spivak et al., 2006) and the perfusion rate (see supplementary materials). The decay phase was modeled as a two-stage sequential desensitization process: [INSERT SCHEME 1 HERE] where AR* represents the activated (open channel) state, AR the first desensitized state, and AR the second desensitized state. It was assumed that at the peak of the response, AR' = AR" = 0. The parameters AR* (initial), k 1 , k -1 , k 2 , and k -2 were fitted simultaneously by nonlinear regression analysis to each decay. 
RESULTS
Acetylcholine Concentration Response
ACh-induced inward currents were elicited using various concentrations of the agonist at a fixed treatment time of 4.9 s, and delivered in random order to voltage clamped cells ( Fig. 1) . These currents were mediated by the nAChR, as these cells are devoid of muscarinic receptors (Lambert et al., 1989) . ACh application evoked an inward current whose amplitude was dependent upon its concentration. A maximal activation of this current was seen at approximately 100 µM ACh, and the EC 50 was 40 ± At low ACh concentrations, double exponential decays became difficult or impossible to discern from single exponentials because the signal was smaller and because k 1 appoached k 2 ( Fig. 2A and 2C ). As a result, parameters for the second stage of desensitization were more prone to error or were impossible to obtain (such as the k 2 and k -2 values for 1 µM ACh in Fig. 2 ). Figure 2 depicts the relationships between the fitted rate constants to the ACh concentration. The rate constant k 1 increased about 16-fold as a function of the ACh concentration (1 to 1000 µM; Fig. 2A ) and was directly proportional to the activated state AR* ( Fig. 2B) , as required by the desensitization scheme. In contrast, k 2 showed only a slight tendency to increase with the ACh concentration ( The decays of the ACh-induced currents in the presence of AEA were fitted to the desensitization scheme given above to derive the four rate constants. Figure 3C shows that the values of the first forward rate constant for desensitization k 1 , determined for AEA concentrations up to 2 µM increased as exponential functions of time, and their asymptotic maxima increased as linear functions of the AEA concentration ( Fig. 3D) with no sign of saturation. In contrast, the estimates of all of the remaining rate constants were independent of time and insensitive to AEA (Fig. 3 E-G).
We next investigated whether cannabinoid receptors were involved in the inhibitory effects of AEA on α 4β2 nAChR function, or whether there were also direct effects of other cannabinoid ligands on this nAChR. The primary psychoactive constituent of cannabis, ∆ 9 -THC (1 µM), did not alter the amplitudes or the kinetics of the current elicited by ACh (Fig. 4 ). In addition, the cannabinoid receptor antagonist SR-141716A (rimonabant), which had no effect by itself on ACh responses (n=3), did not significantly alter the effects of AEA on the α 4β2 nAChR ( Fig. 5A , C, D, and E).
However, SR-141716A did seem to reverse slightly the effect of AEA on rate constant k 1 (Fig. 5B ).
The site of the AEA action was further tested by including the endocannabinoid (1 µM) in the pipette solution. To prevent possible hydrolysis of AEA to arachidonic acid by fatty acid amide hydrolase (FAAH), 1 µM URB 597, the specific and potent FAAH inhibitor (Kathuria et al., 2003) was included in the patch pipette. Application of ACh at 3 min intervals for up to 40 min showed a rundown of peak amplitudes to 80 ± 11% (n=6), which was indistinguishable from the control value of 88 ± 5% (n=4; P > 0.5). In addition, the value of the first forward rate constant for desensitization, k 1 increased slightly from 1.52 ± 0.34 s -1 to 1.96 ± 0.61 s -1 at 30 min (n=6), values that are in complete agreement with controls (P > 0.4) and in striking contrast to the effects of 1 µM AEA applied extracellularly (Fig. 3C) . These results require more thorough study, however, because hydrophobic compounds may not be efficiently delivered by means of a patch pipette (Akk et al., 2005) .
In earlier studies, AEA has been shown to increase intracellular Ca 2+ levels (for review Oz, 2006 replaced calcium with equimolar barium in the extracellular medium and tested the effects of 0.5 µM AEA on 30 µM ACh responses. On comparing the results to those obtained in calcium-containing medium, we found no change in peak amplitudes and rate constants k -1 , k 2 , and k -2 (4 or 5 cells, monitored for 40 min). The rate constant k 1 , however, was 61 ± 3% of the corresponding value in calcium-containing medium for all time points including those before the application of AEA. Because of the constant percent decrease of k 1 on the cells even before AEA treatment, we believe that the barium-containing medium, rather than antagonizing AEA directly, lowered the free energy of the activated state, and that the barium and AEA effects were independent and
additive. to the frequency of channel activation. Therefore, the extent of AEA inhibition of the α 4β2 nAChR-mediated response was compared in cells exposed to ACh at 6 min intervals with those exposed at 3 min intervals. However, increasing the ACh test interval to 6 minutes during AEA (1 µM) application gave responses indistinguishable from those tested at the 3 min interval, indicating that the block by AEA was not use dependent ( Fig. 3B ).
If the slow onset of the AEA effects was a consequence of its partitioning into the lipid membrane, then the time course of reversal of the AEA effect should be similar to onset during simple washout, but greatly enhanced if a lipid scavenger is included in the extracellular solution. The offset kinetics were first tested under normal conditions ( Fig.   6 A and B) . Because our objective was to characterize the reversal of the AEA treatment by monitoring this phase as long as possible, we applied the endocannabinoid for only 3 min prior to beginning the wash phase. This application period is seen in Fig. 6 A and B as the gap between the last control test and the first test after beginning the wash period denoted by the pair of dotted vertical lines. The peak ACh-induced current amplitudes were reduced to 60% of control by this application of AEA and intersected the control rundown curve at about 50 min after the start of the wash ( Fig 6A; the dashed line, taken from Fig. 3B ). The recovery of the k 1 values were clearer, approaching the control value during the wash phase as an exponential function of time with a time constant of 30 ± 4 min (Fig. 6B ). In the next series of experiments, we recorded control responses to ACh in BSA-free medium. The cells were then treated with 1 µ M AEA for 10 min followed by a wash with 1 mg/mL of lipid free BSA (e.g. Poling et al., 1996) . Figures 6C and 6D reveal that the recovery of peak amplitudes and k 1 were complete by 9 min, an order of This article has not been copyedited and formatted. The final version may differ from this version. magnitude faster than recovery without BSA (the time constants were 2.2 and 1.7 min, respectively). In addition, the amplitudes of the ACh-evoked currents during BSA treatment appeared to be larger than those observed during the control baseline period, observed prior to AEA application ( Fig 6C) . We speculated that this might result from the tonic inhibition of the α 4β2 nAChR by an endogenous lipid molecule that was sensitive to BSA. To test this hypothesis, we examined the effects of BSA on AChevoked currents in the absence of AEA application (Fig. 7) . Treatment with BSA alone (14 min) caused significant effects on peak amplitudes of the α 4β2 nAChR currents as well as the rate constant k 1 that were opposite to those caused by AEA. Furthermore the effects of BSA were reversible by a brief washing with control saline. BSA had no effects on the other rate constants.
DISCUSSION
The present results indicate that the endocannabinoid AEA inhibited the function of the α 4β2 nAChR in a cannabinoid receptor-independent manner. Furthermore, this effect was relatively selective for this cannabinoid receptor agonist because the phytochemical agonist ∆ 9 -THC was ineffective in modulating nAChR-mediated ion currents, and the cannabinoid antagonist SR-141716A did not affect the AEA inhibition of α 4β2 nAChR function. These results therefore indicate that AEA acts directly at the α 4β2 nAChR independently of cannabinoid receptors to modulate the strength of nicotinic signaling. In agreement with these results, AEA has also been found to modulate the functions of other voltage-gated (Poling et al., 1996; Oz et al., 2000; Oliver et al., 2004; Fisyunov et al., 2006) and ligand-gated (Barann et al., 2002; Oz et al., 2002; 2004a) ion channels, as well as other integral membrane proteins at a similar concentration range and in a cannabinoid-receptor independent manner (for a review see Oz, 2006 AEA in the pipette, ACh produced currents with amplitudes and decay kinetics that were indistinguishable from controls, suggesting that the site of AEA action was extracellular.
However, given the rapid traverse of fatty acids across phospholipid membranes (e.g. Kamp and Hamilton, 1993) and the caution required in interpreting intracellular application of hydrophobic substances (Akk et al., 2005) , we view the site of AEA action as inconclusive.
In agreement with earlier findings (e.g. Paradiso and Steinbach, 2003; Wu et al., 2004) , α 4β2 nAChR currents in voltage clamped SH-EP1 cells decayed with double exponential kinetics, which can be analyzed as two mechanistic states of desensitization (Scheme 1). Though a simplification of comprehensive schemes (e.g. Paradiso and Steinbach, 2003; Quick and Lester, 2002) , Scheme 1 was useful because it accounted for the data by ascribing a mechanism to the decays in the ACh currents, both alone and in the presence of AEA Thus, the rate constant k 1 , which leads from the activated to the first desensitized state, was found to be a function of the ACh concentration ( Fig. 1A) and was directly proportional to the activated state (AChR* of Scheme 1) of the nAChR (Fig. 1B) , whereas the other rate constants were independent of these variables (Fig. 1C-1F ). Therefore, this model parsimoniously described our data while providing mechanistic insight into the desensitization of the α 4 β 2 -nAChR by AEA. The most striking effect of AEA in this model was the linear increase in the value of k 1 with increasing AEA concentrations, such that at 2 µM AEA it was 27-fold higher than the control value. The other rate constants remained unchanged by AEA. This selectivity can be understood in terms of energy states of the α 4β2 nAChR. If the activation energy barrier between the activated (AChR*) and the first desensitized state (AChR'; Scheme This article has not been copyedited and formatted. The final version may differ from this version. 1) were lowered by AEA (Fig. 8, dotted line) , then both k 1 and k -1 would have increased.
However, if AEA increased the energy of the activated state AR* (Fig. 8, dashed channel blockade, but three min after BSA treatment the decay (expressed as k 1 ) was still accelerated (Fig. 6D). (2) There was an absence of use-dependent blockade (Fig. 3B) , and AEA had almost no effect when co-administered with ACh without preincubation (data not shown). Open channel blockade could occur in the absence of AEA in free solution if AEA first dissolved into the lipid membrane and diffused into a non-annular lipid space to block the ion channel. Scheme 1, validated by the ACh concentration response curves, would then be enlarged by adding a second pathway from the activated to the blocked state. Because this model predicted alterations in all four parameters that we did not observe, we therefore conclude that Scheme 1 remains the most parsimonious and useful model for the data.
The striking decrease in the peak amplitudes seen in the presence of AEA could be a consequence of the increase in the rate of desensitization (k 1 ), as described in our This article has not been copyedited and formatted. The final version may differ from this version. model. It is important to understand that, whereas the fastest perfusion-limited rise time that can be observed in our system is the 2-3 ms rise time of the junction potential occurring with a solution change, the rise time for the ACh currents was ~40 ms. This discrepancy likely reflects the time required for ACh to diffuse through the unstirred layer of extracellular solution that surrounds cultured cells under the present conditions.
A similar kinetic slowing of the effects of the opioid antagonist naloxone (Spivak et al., 2006) and AEA (Bojesen and Hansen, 2006) by the unstirred layer have also recently been described. In the presence of AEA, this may have led to a desensitization gradient across the cell in which nAChRs in regions of the cell membrane that were activated first by ACh, desensitized before more distal nAChRs were activated. Simulations (see supplemental information) that convolve this diffusion of ACh through the unstirred layer with α 4β2 nAChR desensitization show that about 80% of the decrease in response amplitude can be attributed to this mechanism. A consistent and parsimonious explanation for the remainder of the decrease is to ascribe it to desensitization of the nAChR in the closed state, a process supported by previous work of others and which seems particularly important for the agonist nicotine (Paradiso and Steinbach, 2003) Another result of the kinetic analysis was that the increase in k 1 showed no sign of approaching saturation over the entire effective range of AEA concentrations (Fig. 3D ). This is consistent with our molecular view of the effect of AEA on ion channels. Given an estimated octanol-water partition coefficient of 1.7x10 5 (Log P from ChemDraw, CambridgeSoft, Cambridge MA), it is likely that AEA will easily partition into the biological membrane, where it can rapidly displace some of the ~40 annular (Ellena et al., 1983 ) and possibly the non-annular lipids that are in intimate contact with the receptor. Such alterations of the lipid environment, which include hydrophobic mismatch between lipids and proteins, changes in membrane viscosity, changes in the interfacial curvature, altered lateral pressure profile, and shifts in lipid dipole potential and surface potential can alter the functions of transmembrane proteins (e.g. Barrantes, 2004; Lundbaek, 2006) . Specifically, we propose that AEA has raised the free energy of the activated state AR*.
Anandamide belongs to a larger group of signaling lipids consisting of amides of long-chain polyunsaturated fatty acids (for a review see Howlett et al., 2002) . Earlier studies on nAChRs demonstrated that fatty acids could modulate their function via a direct action (for a review see Barrantes, 2004) . Thus it is possible that AEA and fatty acid based molecules may share common sites of action on various membrane proteins (for a review see Oz, 2006) . Depending upon local concentrations under basal conditions, the modulatory actions of AEA on nAChRs might be tonically present, as well as phasically elevated by neuronal activity that results in the release of this, and possibly other endocannabinoids (Freund et al., 2003) . Evidence exists for both possibilities in the CNS. For example, the exposure of neurons to chronic ethanol results in an increased accumulation of AEA (Basavarajappa and Hungund, 2002) , and chronic ethanol intake increases AEA levels in various brain regions involved in drug abuse (Gonzalez et al., 2004) . Thus, alterations in AEA levels in the CNS by abused drugs and/or other pathophysiological conditions may cause changes in tonic activity of nAChRs and/or alter the actions of other abusive substances such as ethanol on nAChR function (Oz et al., 2005) . Additionally, our study provides further support for the idea that AEA may tonically inhibit α 4β2 nAChRs, since the effects of exogenously applied This article has not been copyedited and formatted. The final version may differ from this version. AEA were reversed by lipid scavenging with BSA (Bojesen and Hansen, 2003) , and α 4β2 nAChR function was increased by BSA in naïve cells. Also consistent with this proposal is the observation that direct manipulation of the membrane lipid composition causes significant alterations in the activity of nicotinic receptors (Baenziger et al., 2000) , suggesting that nAChRs do indeed function under the tonic influence of membrane lipids.
In the central nervous system, α 4β2 nACh receptors are located both pre-and postsynaptically and play an important modulatory role in synaptic transmission (Sher et al., 2004; Dani and Bertrand, 2007) . Because AEA acts at the nAChR at physiologically relevant concentrations (discussed in Oz, 2006) and given the presence of α 4β2 nACh receptors in these critical locations, it is possible that the activity of the α 4β2-nACh receptor function is regulated by both tonic and phasic AEA in situ. Whereas the α 4β2 nACh receptor represents a novel molecular target for AEA, previously observed interactions between ∆ 9 -THC and systemic nicotinic pharmacology (for reviews see Castane et al., 2006; Viveros et al., 2006) can not be explained by our findings. Other studies indicate that the function of 5-HT 3 and Glycine receptors are also modulated by AEA and by ∆ 9 -THC (Barann et al., 2002; Oz et al., 2002; Hejazi et al., 2006) . However, the present results indicate that AEA, but not ∆ 9 -THC, inhibits α 4β2 nAChR function.
Similarly, differential effects of AEA and ∆ 9 -THC have been reported on Ca 2+ channels (Oz et al., 2004a) , K + channels (Poling et al., 1996) , α 7 -nAChRs (Oz et al., 2004b) , and NMDA receptors (Hampson et al., 1998) suggesting that AEA and ∆ 9 -THC do not share a common binding site among various membrane proteins.
This article has not been copyedited and formatted. The final version may differ from this version. nAChR, denoted AR*, sequentially converting to desensitized states AR' and AR" by the first order forward and backward rate constants k 1 , k -1 and k 2 , k -2 , respectively. 
